109 related articles for article (PubMed ID: 37548201)
1. The value of RACK1 and peripheral blood M2/M1 monocyte ratio on the prognosis of patients with oral squamous cell carcinoma.
Liu H; Wu R; Bi L; Xu X; Chen H
Pak J Pharm Sci; 2023 Mar; 36(2(Special)):631-638. PubMed ID: 37548201
[TBL] [Abstract][Full Text] [Related]
2. [Study on the correlation between combined detection of RACK1 and M2/M1 in oral squamous cell carcinoma and prognosis of the patients].
Zhu J; Xu T; Song DH; Wu SB
Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):517-522. PubMed ID: 36758601
[TBL] [Abstract][Full Text] [Related]
3. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.
Dan H; Liu S; Liu J; Liu D; Yin F; Wei Z; Wang J; Zhou Y; Jiang L; Ji N; Zeng X; Li J; Chen Q
Mol Oncol; 2020 Apr; 14(4):795-807. PubMed ID: 31997535
[TBL] [Abstract][Full Text] [Related]
4. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
[TBL] [Abstract][Full Text] [Related]
5. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
Li Y; Li R; Qin H; He H; Li S
Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
[TBL] [Abstract][Full Text] [Related]
6. RACK1 is an organ-specific prognostic predictor in OSCC.
Liu S; Liu J; Wang J; Cheng J; Zeng X; Ji N; Li J; Chen Q
Oral Oncol; 2018 Jan; 76():22-26. PubMed ID: 29290282
[TBL] [Abstract][Full Text] [Related]
7. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.
Wang Z; Jiang L; Huang C; Li Z; Chen L; Gou L; Chen P; Tong A; Tang M; Gao F; Shen J; Zhang Y; Bai J; Zhou M; Miao D; Chen Q
Mol Cell Proteomics; 2008 Sep; 7(9):1639-50. PubMed ID: 18458027
[TBL] [Abstract][Full Text] [Related]
9. The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma.
Eltohami YI; Kao HK; Lao WW; Huang Y; Abdelrahman M; Liao CT; Yen TC; Chang KP
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1042-1050. PubMed ID: 29336202
[TBL] [Abstract][Full Text] [Related]
10. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
[TBL] [Abstract][Full Text] [Related]
11. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
Chi J; Liu Y; Yang L; Yang J
J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
[TBL] [Abstract][Full Text] [Related]
12. Relationship between p16 expression and prognosis in different anatomic subsites of OSCC.
Ni Y; Zhang X; Wan Y; Dun Tang K; Xiao Y; Jing Y; Song Y; Huang X; Punyadeera C; Hu Q
Cancer Biomark; 2019; 26(3):375-383. PubMed ID: 31594213
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma.
Wang Z; Zhang H; Zhai Y; Li F; Shi X; Ying M
Front Immunol; 2022; 13():843322. PubMed ID: 35401551
[TBL] [Abstract][Full Text] [Related]
15. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67.
Wang Z; Zhang B; Jiang L; Zeng X; Chen Y; Feng X; Guo Y; Chen Q
Eur J Cancer; 2009 Feb; 45(3):490-6. PubMed ID: 19087901
[TBL] [Abstract][Full Text] [Related]
16. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Synuclein-
Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
[TBL] [Abstract][Full Text] [Related]
18. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
19. [Periodontitis Promotes the Progression of Oral Squamous Cell Carcinoma by Inducing Macrophage M2 Polarization].
Li J; Wei W; Tang BY; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):83-90. PubMed ID: 36647648
[TBL] [Abstract][Full Text] [Related]
20. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
